TITLE

Long-term results of lung volume reduction surgery

AUTHOR(S)
Fujimoto, T.; Teschler, H.; Hillejan, L.; Zaboura, G.; Stamatis, G.
PUB. DATE
March 2002
SOURCE
European Journal of Cardio-Thoracic Surgery;Mar2002, Vol. 21 Issue 3, p483
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Lung volume reduction surgery (LVRS) is effective in the short and intermediate term for the improvement of pulmonary function and subjective symptoms in selected patients with advanced emphysema. The purpose of this study was to examine the long-term functional results of LVRS and to investigate which subgroups would benefit in terms of long-term survival. Methods: All records of the patients who underwent LVRS between 1994 and, 1998 at our hospital were reviewed. Results: Eighty-eight consecutive patients underwent LVRS during the period. There were 62 men and 26 women with an average age of 56.1 years (range 34–72 years). Eleven patients with α1-antitrypsin deficiency were included. The perioperative mortality rate (<90 days) was 2.3% (n=2). Total lung capacity (7.5±0.3 l) and residual volume (4.8±0.3 l) at 3 years remained lower than baseline (9.2±0.2 l, 6.5±0.2 l, each) (P<0.001). The mean forced expiratory volume in 1 s (FEV1) at 3 years (0.86±0.08 l) was higher than baseline (0.78±0.02 l), but the difference did not reach statistical significance. The FEV1 of the patients with α1-antitrypsin deficiency and of those with respiratory bronchiolitis returned to baseline at one year after LVRS and showed further deterioration. Overall survival rate at 5 years was 71.0% with the mean length of follow-up of 54.2 months. The survival difference was statistically significant between patients with preoperative FEV1≥28.5% and those with FEV1<28.5% (P=0.0152). Conclusions: The improvement of total lung capacity and residual volume persisted long after the operation. Patients with α1-antitrypsin deficiency and those with bronchiolitis showed early deterioration of the lung function. Patients with higher preoperative FEV1 had a survival benefit. The favorable long-term survival might justify LVRS for the treatment of selected patients with severe emphysema.
ACCESSION #
7766953

 

Related Articles

  • Chronic obstructive pulmonary disease • 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Meyers, B.F.; Patterson, G.A. // Thorax;Jul2003, Vol. 58 Issue 7, p634 

    There are currently three surgical treatments for emphysema: bullectomy, lung transplantation, and lung volume reduction surgery (LVRS). Unfortunately, most emphysema patients are poor candidates for any surgical intervention. A meticulous selection process is favoured in which indications and...

  • Smokers' Second Wind? Song, Sora // Time;6/2/2003, Vol. 161 Issue 22, p83 

    Discusses lung-volume reduction operations that are designed to decrease the capacity of the lungs in an attempt to improve their overall efficiency. Benefits of the surgery for people with emphysema; Results of a study by the National Institutes of Health; Effects of the surgery on people...

  • Mechanical Events In Physiopathology Of Idiopathic Pulmonary Emphysema: A Theoretical Analysis. Nazari, Stefano // Internet Journal of Pathology;2002, Vol. 2 Issue 2, p26 

    Lung volume reduction (LVR) surgery, now quite frequently used as a therapeutic option in lung emphysema, is aimed at advantageously interfering with the structural alterations of bronchoalveolar architecture and the thoracic cage and diaphragm changes characterizing the emphysema. All the...

  • Emphysema sufferers breathe easier. Miller, John D. // CMAJ: Canadian Medical Association Journal;11/02/99, Vol. 161 Issue 9, p1140 

    Reports on the use of lung-reduction surgery for people with emphysema. Advocation for the use of lung-volume-reduction surgery (LVRS); Benefits patients received following the procedure.

  • Lung Volume Reduction Surgery vs Medical Treatment: For Patients with Advanced Emphysema.  // Cardiopulmonary Physical Therapy Journal (American Physical Ther;Sep2005, Vol. 16 Issue 3, p24 

    Cites key research findings in 2005 comparing the efficacy of lung volume reduction surgery and medical treatment in patients with advanced emphysema. Therapeutic value of lung volume reduction surgery; Analysis of pertinent topics and relevant issues; Implications for studies of cardiopulmonary...

  • Emphysema: time to say farewell to therapeutic nihilism. Zoumot, Zaid; Jordan, Simon; Hopkinson, Nicholas S. // Thorax;Nov2014, Vol. 69 Issue 11, p973 

    The article focuses on the need to end the current trend of therapeutic nihilism in emphysema. Topics discussed include neglecting lung volume reduction surgery (LVRS) in the treatment of emphysema, increasing bronchoscopic approaches for lung volume reduction in emphysema and the development of...

  • Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severity. Perotin, Jeanne-Marie; Adam, Damien; Vella-Boucaud, Juliette; Delepine, Gonzague; Sandu, Sebastian; Jonvel, Anne-Carole; Prevost, Alain; Berthiot, Gérard; Pison, Christophe; Lebargy, François; Birembaut, Philippe; Coraux, Christelle; Deslee, Gaëtan // Respiratory Research;2014, Vol. 15 Issue 11, p1 

    Background: Airway epithelium integrity is essential to maintain its role of mechanical and functional barrier. Recurrent epithelial injuries require a complex mechanism of repair to restore its integrity. In chronic obstructive pulmonary disease (COPD), an abnormal airway epithelial repair may...

  • Chronic obstructive pulmonary disease · 2: Pathology and biochemistry of emphysema. Hogg, J.C.; Senior, R.M. // Thorax;Sep2002, Vol. 57 Issue 9, p830 

    Part 2. Examines the pathology and biochemistry of emphysema. Cells responsible for the degradation of extracellular matrix in emphysema; Proteinase-antiproteinase hypothesis; Proteinases involved in alveolar septal destruction.

  • Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. Goldstein, R.S.; Todd, T.R.J.; Guyatt, G.; Keshavjee, S.; Dolmage, T.E.; van Rooy, S.; Krip, B.; Maltais, F.; LeBlanc, P.; Pakhale, S.; Waddell, T.K. // Thorax;May2003, Vol. 58 Issue 5, p405 

    Background: The clinical value of LVRS has been questioned in the absence of trials comparing it with pulmonary rehabilitation, the prevailing standard of care in COPD. Patients with heterogeneous emphysema are more likely to benefit from volume reduction than those with homogeneous disease....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics